Clinical trial
Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C
NCT00262379 · University Hospital, Angers, Other · Completed
Key facts
| NCT number | NCT00262379 |
|---|---|
| Title | Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C |
| Official title | Multicenter Study, Randomized and Pragmatic, Comparing Two Therapeutic Strategies : Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C and Treated by Combination Therapy Peginterferon Alfa-2a Plus Ribavirin |
| Lead sponsor | University Hospital, Angers, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | epoetin beta (NeoRecormon®) |
| Enrollment | 229 |
| Start date | Dec 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Dec 6, 2005 |
| Last update posted | Dec 12, 2014 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: